MEDPOINT DIGITAL Trademark

Trademark Overview

On Monday, April 11, 2011, a trademark application was filed for MEDPOINT DIGITAL with the United States Patent and Trademark Office. The USPTO has given the MEDPOINT DIGITAL trademark a serial number of 85291510. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, July 28, 2023. This trademark is owned by Medpoint Communications, Inc.. The MEDPOINT DIGITAL trademark is filed in the Advertising, Business and Retail Services category with the following description:

Development of medical product marketing strategies, concepts and tactics, namely, audience development, brand awareness, online community building and digital word of mouth communications; Business consulting and information management in the field of clinical trials, namely, management and compilation of digital and web site based systems and providing clinical research adverse event adjudication digital systems to medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval in the field of clinical trials for business purposes
medpoint digital

General Information

Serial Number85291510
Word MarkMEDPOINT DIGITAL
Filing DateMonday, April 11, 2011
Status710 - CANCELLED - SECTION 8
Status DateFriday, July 28, 2023
Registration Number4276401
Registration DateTuesday, January 15, 2013
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 20, 2012

Trademark Statements

Pseudo MarkMED POINT DIGITAL
Goods and ServicesDevelopment of medical product marketing strategies, concepts and tactics, namely, audience development, brand awareness, online community building and digital word of mouth communications; Business consulting and information management in the field of clinical trials, namely, management and compilation of digital and web site based systems and providing clinical research adverse event adjudication digital systems to medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval in the field of clinical trials for business purposes
Disclaimer with Predetermined Text"DIGITAL"

Classification Information

International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, July 28, 2023
Primary Code035
First Use Anywhere DateThursday, July 28, 2011
First Use In Commerce DateThursday, July 28, 2011

Trademark Owner History

Party NameMedpoint Communications, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressEvanston, IL 60201
Party NameMedpoint Communications, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressEvanston, IL 60201
Party NameMedpoint Communications, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressEvanston, IL 60201

Trademark Events

Event DateEvent Description
Friday, July 28, 2023CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
Saturday, January 15, 2022COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Monday, March 18, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, March 18, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, November 16, 2018NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Friday, November 16, 2018REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Thursday, November 15, 2018CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, October 30, 2018TEAS SECTION 8 & 15 RECEIVED
Monday, January 15, 2018COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, August 21, 2015ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, August 21, 2015TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, January 15, 2013REGISTERED-PRINCIPAL REGISTER
Saturday, December 8, 2012NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Friday, December 7, 2012LAW OFFICE REGISTRATION REVIEW COMPLETED
Friday, November 30, 2012ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Monday, November 19, 2012STATEMENT OF USE PROCESSING COMPLETE
Thursday, November 15, 2012USE AMENDMENT FILED
Monday, November 19, 2012CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, November 15, 2012TEAS STATEMENT OF USE RECEIVED
Tuesday, May 15, 2012NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 20, 2012OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 20, 2012PUBLISHED FOR OPPOSITION
Wednesday, February 29, 2012NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, February 10, 2012LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, February 7, 2012ASSIGNED TO LIE
Tuesday, January 24, 2012APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, January 24, 2012EXAMINER'S AMENDMENT ENTERED
Tuesday, January 24, 2012NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, January 24, 2012EXAMINERS AMENDMENT E-MAILED
Tuesday, January 24, 2012EXAMINERS AMENDMENT -WRITTEN
Friday, July 29, 2011NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, July 29, 2011NON-FINAL ACTION E-MAILED
Friday, July 29, 2011NON-FINAL ACTION WRITTEN
Thursday, July 14, 2011ASSIGNED TO EXAMINER
Friday, April 15, 2011NOTICE OF PSEUDO MARK MAILED
Thursday, April 14, 2011NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, April 14, 2011NEW APPLICATION ENTERED

Related Keywords

digital medpoint clinical trials business development field research systems management namely